Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted therapies in epithelial ovarian cancer.
Dean E, El-Helw L, Hasan J. Dean E, et al. Cancers (Basel). 2010 Feb 23;2(1):88-113. doi: 10.3390/cancers2010088. Cancers (Basel). 2010. PMID: 24281034 Free PMC article.
Malignant bowel obstruction in advanced ovarian cancer.
Dean E, Khoja L, Clamp A, Jayson GC, Goonetilleke D, Conway AM, Hasan J. Dean E, et al. Future Oncol. 2017 Mar;13(6):513-521. doi: 10.2217/fon-2016-0431. Epub 2017 Jan 18. Future Oncol. 2017. PMID: 28095701
IAPs as a target for anticancer therapy.
Danson S, Dean E, Dive C, Ranson M. Danson S, et al. Among authors: dean e. Curr Cancer Drug Targets. 2007 Dec;7(8):785-94. doi: 10.2174/156800907783220471. Curr Cancer Drug Targets. 2007. PMID: 18220537 Review.
Selumetinib in the treatment of non-small-cell lung cancer.
Bernabé R, Patrao A, Carter L, Blackhall F, Dean E. Bernabé R, et al. Among authors: dean e. Future Oncol. 2016 Nov;12(22):2545-2560. doi: 10.2217/fon-2016-0132. Epub 2016 Jul 28. Future Oncol. 2016. PMID: 27467210 Review.
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin.
Ranson M, Shaw H, Wolf J, Hamilton M, McCarthy S, Dean E, Reid A, Judson I. Ranson M, et al. Among authors: dean e. Cancer Chemother Pharmacol. 2010 May;66(1):53-8. doi: 10.1007/s00280-009-1133-3. Epub 2009 Dec 3. Cancer Chemother Pharmacol. 2010. PMID: 19956953 Clinical Trial.
905 results